NCT06426147View on ClinicalTrials.gov

L-citrulline to Improve Adverse Outcomes in Admitted Children (EChiLiBRiST, Clinical Trial 2, Inpatients)

NANot yet recruitingINTERVENTIONAL
Enrollment

2,200

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

January 1, 2027

Study Completion Date

April 1, 2027

Conditions
Infectious DiseaseInfectionsChild, Only
Interventions
DIETARY_SUPPLEMENT

L-citrulline

1 or 2 sachets every 12 hours (200-300mg/kg/day depending on weight-band) for 28 days

DIETARY_SUPPLEMENT

Placebo

1 or 2 sachets every 12 hours (depending on weight-band) for 28 days

All Listed Sponsors
lead

Barcelona Institute for Global Health

OTHER

NCT06426147 - L-citrulline to Improve Adverse Outcomes in Admitted Children (EChiLiBRiST, Clinical Trial 2, Inpatients) | Biotech Hunter | Biotech Hunter